184 related articles for article (PubMed ID: 22009011)
1. Myelofibrosis: a cause of increased transfusion requirement in a child with β-thalassemia intermedia.
Nirupam N; Maheshwari A; Rath B; Chandra J; Kumar P; Basu S; Nangia A
J Pediatr Hematol Oncol; 2012 Mar; 34(2):143-5. PubMed ID: 22009011
[TBL] [Abstract][Full Text] [Related]
2. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D
Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of hydroxyurea (HU) in reduction of pack red cell (PRC) transfusion requirement among children having beta-thalassemia major: Karachi HU trial (KHUT).
Ansari SH; Shamsi TS; Siddiqui FJ; Irfan M; Perveen K; Farzana T; Panjwani VK; Yousuf A; Mehboob T
J Pediatr Hematol Oncol; 2007 Nov; 29(11):743-6. PubMed ID: 17984691
[TBL] [Abstract][Full Text] [Related]
4. Thalassemia intermedia: revisited.
Taher A; Isma'eel H; Cappellini MD
Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
[TBL] [Abstract][Full Text] [Related]
5. Heart failure in beta-thalassemia syndromes: a decade of progress.
Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
[TBL] [Abstract][Full Text] [Related]
6. Beta-thalassemia: the Lebanese experience.
Inati A; Zeineh N; Isma'eel H; Koussa S; Gharzuddine W; Taher A
Clin Lab Haematol; 2006 Aug; 28(4):217-27. PubMed ID: 16898958
[TBL] [Abstract][Full Text] [Related]
7. Response to hydroxyurea therapy in beta-thalassemia.
Koren A; Levin C; Dgany O; Kransnov T; Elhasid R; Zalman L; Palmor H; Tamary H
Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
[TBL] [Abstract][Full Text] [Related]
8. Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with beta-thalassemia: challenges in treatment.
Hannema SE; Brand A; van Meurs A; Smiers FJ
Transfusion; 2010 Feb; 50(2):429-32. PubMed ID: 19788508
[TBL] [Abstract][Full Text] [Related]
9. Wheat grass juice reduces transfusion requirement in patients with thalassemia major: a pilot study.
Marawaha RK; Bansal D; Kaur S; Trehan A
Indian Pediatr; 2004 Jul; 41(7):716-20. PubMed ID: 15297687
[TBL] [Abstract][Full Text] [Related]
10. Extramedullary hematopoiesis with spinal cord compression in a child with thalassemia intermedia.
Ileri T; Azik F; Ertem M; Uysal Z; Gozdasoglu S
J Pediatr Hematol Oncol; 2009 Sep; 31(9):681-3. PubMed ID: 19687759
[TBL] [Abstract][Full Text] [Related]
11. Alpha and beta thalassemia.
Muncie HL; Campbell J
Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
[TBL] [Abstract][Full Text] [Related]
12. [Beta-thalassemia: clinical manifestations].
Perrimond H
Bull Soc Pathol Exot; 2001 May; 94(2):92-4. PubMed ID: 11475035
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia.
Ansari SH; Shamsi TS; Ashraf M; Perveen K; Farzana T; Bohray M; Erum S; Mehboob T
J Pediatr Hematol Oncol; 2011 Jul; 33(5):339-43. PubMed ID: 21602718
[TBL] [Abstract][Full Text] [Related]
14. Plasma chitotriosidase activity in patients with beta-thalassemia.
Altarescu G; Rudensky B; Abrahamov A; Goldfarb A; Rund D; Zimran A; Elstein D
Am J Hematol; 2002 Sep; 71(1):7-10. PubMed ID: 12221666
[TBL] [Abstract][Full Text] [Related]
15. Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia.
Karimi M; Mohammadi F; Behmanesh F; Samani SM; Borzouee M; Amoozgar H; Haghpanah S
Eur J Haematol; 2010 Jan; 84(1):52-8. PubMed ID: 19799627
[TBL] [Abstract][Full Text] [Related]
16. Transfusion therapy and alloimmunization in Thalassemia Intermedia: a 10 year experience at a tertiary care university hospital.
Al-Riyami AZ; Al-Mahrooqi S; Al-Hinai S; Al-Hosni S; Al-Madhani A; Daar S
Transfus Apher Sci; 2014 Aug; 51(1):42-6. PubMed ID: 24816438
[TBL] [Abstract][Full Text] [Related]
17. Switch from beta-thalassemia major to beta-thalassemia intermedia after secondary graft failure.
Mellouli F; Ksouri H; Lakhal A; Torjmen L; Abdelkefi A; Ladeb S; Hmida S; Othman TB; Béjaoui M
Exp Clin Transplant; 2010 Sep; 8(3):269-71. PubMed ID: 20716049
[TBL] [Abstract][Full Text] [Related]
18. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
Viprakasit V; Tanphaichitr VS; Mahasandana C; Assteerawatt A; Suwantol L; Veerakul G; Kankirawatana S; Pung-Amritt P; Suvatte V
J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
[TBL] [Abstract][Full Text] [Related]
19. Total hip arthroplasty in beta-thalassemia. Case report and review of the literature.
Wayne AS; Zelicof SB; Sledge CB
Clin Orthop Relat Res; 1993 Sep; (294):149-54. PubMed ID: 8358907
[TBL] [Abstract][Full Text] [Related]
20. Beta thalassemia major and hodgkin lymphoma.
Thapa R; Pal PK; Mukhopadhyay M
J Pediatr Hematol Oncol; 2009 Jun; 31(6):462-3. PubMed ID: 19648798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
